In 2024, Julie Eastland earned $344.61K in total compensation at Zentalis Pharmaceuticals, Inc., including $94.23K salary and $250.00K bonus. 1+ years at the helm of Zentalis Pharmaceuticals, Inc..
Compensation History
Annual executive compensation data for Julie Eastland, including salary, bonuses, and stock awards.
Year
2024
Total Compensation
$344.61K
Salary
$94.23K
Bonus
$250.00K
Other
$383.00
Salary
$94.23KBoard Justification
Our executives make strategic decisions that influence the Company's annual and long-term performance, and we believe it is appropriate to reward performance against achievement of corporate performance goals.
Bonus
$250.00KBoard Justification
The annual cash bonuses for our named executive officers who were employed at the end of January 2025, which bonuses were tied 100% to achievement of 2024 corporate performance goals, were paid out at 95% of target.
Other Compensation
$383.00Board Justification
includes: (i) a cellular phone plan allowance of $200, and (ii) group term life insurance premiums paid by the Company of $183.
Restricted Stock
Board Justification
N/A
Performance Metrics
corporate performance goals related to clinical development, our future pipeline, CMC/quality, culture/people, and financial objectives
Julie Eastland
CEO of Zentalis Pharmaceuticals, Inc.
Education
M.B.A. from Edinburgh University Management School and a B.S. in finance from Colorado State University
Sector of Economy
Healthcare
CEO of Zentalis Pharmaceuticals, Inc. for
1 year 1 month (Nov 2024 - Present)
Previous Experience
Unknown
Other Zentalis Pharmaceuticals, Inc. CEOs
Holdings
Track Julie Eastland's stock holdings and portfolio value over time.
Insider Trading
Julie Eastland's recent stock transactions, purchases, and sales filed with the SEC.
No insider trades found for this CEO.
Rivals
Compare Julie Eastland with competitor CEOs and industry peers.